biotech
Bio-AnalystSupplement research
person
arrow_backExplore/Coenzyme Q10

Coenzyme Q10

Selected research topic

Men's health

Some measured outcomes improved in human comparison studies. Read these findings with their populations and conditions.

Findings from a combination study cannot be attributed to this ingredient alone.

Animal and cell findings do not establish the same effect in people.

Some findings concern patients or people with a deficiency.

Publications for this topic
14
Human comparison publications
1
Publications needing review
4

Findings in the studies

  • sperm density

    • A better result than the comparison group was reported.

      What the comparison group used was not confirmed.

      Patient group · Single ingredient
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      How results were compared
      Results were compared between groups.
      Measurement time
      Not confirmed.
  • motility

    Other human research, including observational studies and reviews
    • A change was reported before and after use. Its cause cannot be isolated.

      Several ingredients were tested together, so this ingredient’s individual effect is unknown.

      Patient group · Combination study · after 3 months / 12 weeks
      Measurement and study conditions
      Study type
      Controlled trial
      Study population
      Human participants · Patient group
      Ingredients tested
      Ingredient combination
      How results were compared
      Changes within the same group were compared. · Study comparison: within-group pre/post change; control group showed no significant change but no direct between-group
      Measurement time
      after 3 months / 12 weeks
  • normal semen analysis results

    Other human research, including observational studies and reviews
    • A change was reported before and after use. Its cause cannot be isolated.

      Several ingredients were tested together, so this ingredient’s individual effect is unknown.

      Patient group · Combination study · after 3 months / 12 weeks
      Measurement and study conditions
      Study type
      Controlled trial
      Study population
      Human participants · Patient group
      Ingredients tested
      Ingredient combination
      How results were compared
      Changes within the same group were compared. · Study comparison: within-group pre/post change; control group showed no significant change but no direct between-group
      Measurement time
      after 3 months / 12 weeks
  • Progressive sperm motility

    Other human research, including observational studies and reviews
    • A change was reported, but the comparison could not be confirmed.

      Several ingredients were tested together, so this ingredient’s individual effect is unknown.

      Patient group · Combination study
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Patient group
      Ingredients tested
      Ingredient combination
      Measurement time
      Not confirmed.
Other measured outcomes (13)
  • Outcome needs clarification

    About this measure

    Original outcome name: SDF

    Other human research, including observational studies and reviews
    • A change was reported before and after use. Its cause cannot be isolated.
      Patient group · Single ingredient · 3 months
      Measurement and study conditions
      Study type
      Clinical trial
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      How results were compared
      Changes within the same group were compared. · Study comparison: Within-participant pre/post change after CoQ10-main-ingredient supplement; no control group reported
      Additional measurement information
      Primary outcome
      Measurement time
      3 months
  • sperm count

    Other human research, including observational studies and reviews
    • An association was observed. This does not establish that the ingredient caused the change.

      Several ingredients were tested together, so this ingredient’s individual effect is unknown.

      Patient group · Combination study · 6 months
      Measurement and study conditions
      Study type
      Observational study
      Study population
      Human participants · Patient group
      Ingredients tested
      Ingredient combination
      How results were compared
      Comparison unclear · Study comparison: reported after treatment; no untreated comparator described
      Additional measurement information
      Secondary outcome
      Measurement time
      6 months
  • sperm density, morphology

    Other human research, including observational studies and reviews
    • A change was reported before and after use. Its cause cannot be isolated.

      Several ingredients were tested together, so this ingredient’s individual effect is unknown.

      Patient group · Combination study · 12 weeks
      Measurement and study conditions
      Study type
      Controlled trial
      Study population
      Human participants · Patient group
      Ingredients tested
      Ingredient combination
      How results were compared
      Changes within the same group were compared. · Study comparison: within-group changes; no significant improvement in either group
      Measurement time
      12 weeks
  • sperm progressive motility

    Other human research, including observational studies and reviews
    • An association was observed. This does not establish that the ingredient caused the change.
      Patient group · Single ingredient · three months
      Measurement and study conditions
      Study type
      Observational study
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      How results were compared
      Comparison unclear · Study comparison: within-group before/after in patients; fertile controls not untreated disease comparator
      Additional measurement information
      Primary outcome
      Measurement time
      three months
  • sperm quality

    Other human research, including observational studies and reviews
    • An association was observed. This does not establish that the ingredient caused the change.
      Patient group · Single ingredient · 3 months
      Measurement and study conditions
      Study type
      Observational study
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      How results were compared
      Comparison unclear · Study comparison: within-group change versus pretreatment values
      Additional measurement information
      Primary outcome
      Measurement time
      3 months
  • vitality

    Other human research, including observational studies and reviews
    • A change was reported before and after use. Its cause cannot be isolated.

      Several ingredients were tested together, so this ingredient’s individual effect is unknown.

      Patient group · Combination study · after 3 months / 12 weeks
      Measurement and study conditions
      Study type
      Controlled trial
      Study population
      Human participants · Patient group
      Ingredients tested
      Ingredient combination
      How results were compared
      Changes within the same group were compared. · Study comparison: within-group pre/post change; control group showed no significant change but no direct between-group
      Measurement time
      after 3 months / 12 weeks
  • post-thawing motility

    Animal and cell research · indirect evidence
    • A change was reported in animal or cell research.
      Single ingredient
      Measurement and study conditions
      Study type
      Controlled trial
      Study population
      This is animal research. The specific characteristics of the subjects need further review.
      Ingredients tested
      Single ingredient
      How results were compared
      Comparison unclear · Study comparison: CoQ10 included in rabbit semen-extender cryopreservation protocol; abstract states post-thaw motilit
      Additional measurement information
      Secondary outcome
      Measurement time
      After cryopreservation and thawing
  • Sperm parameters

    Animal and cell research · indirect evidence
    • A change was reported in animal or cell research.
      Single ingredient
      Measurement and study conditions
      Study type
      Animal study · indirect
      Study population
      This is animal research. The specific characteristics of the subjects need further review.
      Ingredients tested
      Single ingredient
      How results were compared
      Comparison unclear
      Measurement time
      Not confirmed.
  • clinical pregnancy odds

    Research with unclear study subject or type
    • A change was reported, but the comparison could not be confirmed.
      Measurement and study conditions
      Study type
      Meta-analysis
      Study population
      Recorded population category: Patient group. Whether the research involved humans needs confirmation.
      Ingredients tested
      Unknown intervention
      How results were compared
      Study comparison: Pooled comparative clinical pregnancy odds for CoQ10 treatment in male-infertility trials; includes
      Measurement time
      Unspecified; source notes >3-month treatment in a subgroup analysis.
  • seminal CoQ10 levels

    Research with unclear study subject or type
    • A change was reported, but the comparison could not be confirmed.
      Measurement and study conditions
      Study type
      Meta-analysis
      Study population
      Recorded population category: Patient group. Whether the research involved humans needs confirmation.
      Ingredients tested
      Unknown intervention
      How results were compared
      Study comparison: Pooled CoQ10 treatment versus control comparisons; mixed monotherapy and combination evidence limits
      Additional measurement information
      Biomarker
      Measurement time
      Varied; morphology benefit reported in studies longer than three months.
  • seminal volume

    Research with unclear study subject or type
    • A change was reported, but the comparison could not be confirmed.
      Measurement and study conditions
      Study type
      Meta-analysis
      Study population
      Recorded population category: Patient group. Whether the research involved humans needs confirmation.
      Ingredients tested
      Unknown intervention
      How results were compared
      Study comparison: Pooled CoQ10 treatment versus control comparisons; mixed monotherapy and combination evidence limits
      Additional measurement information
      Biomarker
      Measurement time
      Varied; morphology benefit reported in studies longer than three months.
  • sperm concentration

    Research with unclear study subject or type
    • A change was reported, but the comparison could not be confirmed.
      Measurement and study conditions
      Study type
      Meta-analysis
      Study population
      Recorded population category: Patient group. Whether the research involved humans needs confirmation.
      Ingredients tested
      Unknown intervention
      How results were compared
      Study comparison: Pooled CoQ10 treatment versus control comparisons; mixed monotherapy and combination evidence limits
      Additional measurement information
      Biomarker
      Measurement time
      Varied; morphology benefit reported in studies longer than three months.
  • total sperm motility

    Research with unclear study subject or type
    • A change was reported, but the comparison could not be confirmed.
      Measurement and study conditions
      Study type
      Meta-analysis
      Study population
      Recorded population category: Patient group. Whether the research involved humans needs confirmation.
      Ingredients tested
      Unknown intervention
      How results were compared
      Study comparison: Pooled CoQ10 treatment versus control comparisons; mixed monotherapy and combination evidence limits
      Additional measurement information
      Biomarker
      Measurement time
      Varied; morphology benefit reported in studies longer than three months.

This result is held for interpretation. That does not mean research found no effect.

Outcome groups needing additional review (2)
  • progressive motility · Distinct papers needing additional review: 1Interpretation held: 1
  • sperm creatine concentration · Distinct papers needing additional review: 1Direction unclear: 1

One paper can appear under multiple measured outcomes or review reasons, so these counts should not be added together.

Representative outcome and study details

Studies with an unspecified organism reported a change with no confirmed comparison group in clinical pregnancy odds.

Scope not specified · Includes patient groups · comparator not confirmed

1 publications linked to this result

  • Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: B

The 54.4 evidence score includes 1 independent human studies and 1 clinical studies in the representative benefit area. The B tier remains conservative because of limited repetition across independent human clinical studies, too few clinical findings with an explicit effect direction.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 113

Papers linked to this topic 14 · distinct papers 14 · papers with a confirmed human comparison 1 · papers needing additional review 4

A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • clinical pregnancy odds: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • motility: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • normal semen analysis results: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • post-thawing motility: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • progressive motility: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • Progressive sperm motility: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • SDF: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • seminal CoQ10 levels: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • seminal volume: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • sperm concentration: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • sperm count: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • sperm creatine concentration: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • sperm density: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • sperm density, morphology: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • Sperm parameters: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • sperm progressive motility: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • sperm quality: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • total sperm motility: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • vitality: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0

What the research found

sperm density, morphology

A change was reported before and after use. Its cause cannot be isolated.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

motility

A change was reported before and after use. Its cause cannot be isolated.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

normal semen analysis results

A change was reported before and after use. Its cause cannot be isolated.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

sperm density

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

vitality

A change was reported before and after use. Its cause cannot be isolated.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

SDF

A change was reported before and after use. Its cause cannot be isolated.

Other evidence · Single ingredient · Patient group

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

sperm count

An association was observed. This does not establish that the ingredient caused the change.

Observational study · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

sperm progressive motility

An association was observed. This does not establish that the ingredient caused the change.

Observational study · Single ingredient · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

sperm quality

An association was observed. This does not establish that the ingredient caused the change.

Observational study · Single ingredient · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

clinical pregnancy odds

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Unknown intervention · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Progressive sperm motility

A change was reported, but the comparison could not be confirmed.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

seminal CoQ10 levels

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Unknown intervention · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

seminal volume

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Unknown intervention · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

sperm concentration

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Unknown intervention · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

total sperm motility

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Unknown intervention · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

post-thawing motility

A change was reported in animal or cell research.

Animal study · indirect · Single ingredient · General population

This finding comes from animal or cell research. It does not establish the same effect in people.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Sperm parameters

A change was reported in animal or cell research.

Animal study · indirect · Single ingredient · Patient group

This finding comes from animal or cell research. It does not establish the same effect in people.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

progressive motility

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

sperm creatine concentration

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Observational study · Single ingredient · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Other evidence · Unknown intervention · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

No combination cautions are available to show in the current data. This does not guarantee safety.

Review 2 combination findings and 0 findings that outperformed an ingredient alone.

Reported improvements with combinations

Combination findings are grouped by how the study compared them. This is not a recommendation to combine ingredients.

Combinations with reported improvement

The combination showed improvement, but each ingredient's contribution is unclear.

CurcuminThe study suggests a possible synergistic effect of nano-curcumin and CoQ10 on clinical features of migraine compared to monotherapy or placebo.
SeleniumCombined supplementation with selenium and Coenzyme Q10 resulted in significantly improved renal function markers compared to placebo.